ClassID:

21647

A61K2300/00 - page 44 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#12901
20100028266
2010-02-04

Composition and methods for treating allergic response

#12902
20100025185
2010-02-04

Passenger conveyor handrail drive device

#12903
20100022659
2010-01-28

Methods and Compositions for the Treatment of CNS-Related Conditions

#12904
20100022652
2010-01-28

Antimicrobial and Anticoagulant Compositions and Methods

#12905
20100022642
2010-01-28

Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide

#12906
20100022629
2010-01-28

Dietary Methods and Compositions for Enhancing Metabolism and Reducing Reactive Oxygen Species

#12907
20100022602
2010-01-28

PRE-MIXED, READY-TO-USE IV BOLUS NICARDIPINE COMPOSITIONS AND METHODS OF USE

#12908
20100022586
2010-01-28

Bicyclic heteroaryl inhibitors of PDE4

#12909
20100022578
2010-01-28

Macrocyclic inhibitors of hepatitis C virus

#12910
20100022574
2010-01-28

Methods to Treat Pain Using an Alpha-2 Adrenergic Agonist and an Endothelin Antagonist

#12911
20100022568
2010-01-28

ENDOTHELIN RECEPTOR ANTAGONISTS FOR EARLY STAGE IDIOPATHIC PULMONARY FIBROSIS

#12912
20100022567
2010-01-28

Compositions containing pufa and/or uridine and methods of use thereof

#12913
20100022561
2010-01-28

INHIBITORS OF BRUTON'S TYROSINE KINASE

#12914
20100022556
2010-01-28

Therapeutic combinations comprising a long acting dihydropyridine calcium-channel blocker and a statin

#12915
20100022553
2010-01-28

Therapeutic Combination Comprising an Aurora Kinase Inhibitor and Imatinib

#12916
20100022512
2010-01-28

Compositions of CHK1 inhibitors and cyclodextrin

#12917
20100022497
2010-01-28

Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject

#12918
20100022492
2010-01-28

THERAPEUTIC CAUSING CONTRACTION OF MUCOSAL TISSUE, METHOD OF TREATING DISEASES RELATING TO MUCOSAL TISSUES, INJECTOR AND THERAPEUTIC SET

#12919
20100022480
2010-01-28

Solid oral dosage form containing an enhancer

#12920
20100022474
2010-01-28

Polymer controlled induced viscosity fiber system and uses thereof

#12921
20100022471
2010-01-28

Oral Moisturizer for Alleviating Dry Mouth

#12922
20100022464
2010-01-28

FUNCTIONAL FOOD COMPOSITION THAT IS RICH IN PHENOLIC COMPOUNDS AND USE OF SAID COMPOSITION

#12923
20100022462
2010-01-28

APPETITE SUPPRESSANT AND COLON CLEANSING COMPOSITION

#12924
20100022458
2010-01-28

Methods for treating acute acoustic trauma

#12925
20100022457
2010-01-28

Sustained release glp-1 receptor modulators

#12926
20100022456
2010-01-28

Dimeric Prolactin Receptor Ligands

#12927
20100022446
2010-01-28

Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity

#12928
20100022444
2010-01-28

COMBINATION THERAPY FOR MODULATION OF ACTIVITY AND DEVELOPMENT OF CELLS AND TISSUES

#12929
20100021989
2010-01-28

COMPOSITIONS AND METHODS OF CONTROLLING AND ADMINISTERING REDOX SPECIFIC FORMS OF DRUGS, FOODS AND DIETARY SUPPLEMENTS

#12930
20100021575
2010-01-28

Hypolipidemic composition and its use

#12931
20100021573
2010-01-28

COMPOSITIONS AND METHODS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE

#12932
20100021571
2010-01-28

Compositions and methods for treating acne

#12933
20100021570
2010-01-28

Smoking Cessation Treatment By Reducing Nicotine Cravings, Apetite Suppression, And Altering The Perceived Taste Of Tobacco Smoke

#12934
20100021566
2010-01-28

Reverse vitamin K effect via photodynamic oxidation targeted at vascular endothelium, fibrin and blood platelets

#12935
20100021564
2010-01-28

OM vitamin formula

#12936
20100021563
2010-01-28

COMPOSITIONS COMPRISING COCONUT OIL AND METHODS OF USE THEREOF

#12937
20100021555
2010-01-28

Compositions containing high omega-3 and low saturated fatty acid levels

#12938
20100021554
2010-01-28

Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin

#12939
20100021542
2010-01-28

Extended release oral dosage composition

#12940
20100021540
2010-01-28

Tablets and Preparation Thereof

#12941
20100021529
2010-01-28

STEP-DOWN ESTROGEN REGIMEN FOR WOMEN RECEIVING ESTROGEN THERAPY

#12942
20100021524
2010-01-28

PIMETHIXENE DERIVATIVES FOR PROMOTING BONE GROWTH

#12943
20100021505
2010-01-28

Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients

#12944
20100021480
2010-01-28

BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME

#12945
20100021475
2010-01-28

Methods and compositions for inhibiting the growth of hematopoietic malignant cells

#12946
20100021464
2010-01-28

Methods of wound care and treatment

#12947
20100021456
2010-01-28

DRUG FOR INHIBITING,PREVENTING OR TREATMENT OF RHEUMATOID ARTHRITIS

#12948
20100021433
2010-01-28

Disease treatment via developing non-syngeneic graft transplantation

#12949
20100021432
2010-01-28

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

#12950
20100021431
2010-01-28

Agent for promoting the production of thioredoxin

#12951
20100021430
2010-01-28

Horse feed and treatment methods

#12952
20100021429
2010-01-28

Cladribine regimen for treating multiple sclerosis

#12953
20100021428
2010-01-28

Use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (stossel)

#12954
20100021426
2010-01-28

Methods for making and compositions comprising fermentation products of cordyceps sinensis

#12955
20100021421
2010-01-28

Fusion proteins and methods for modulation of immune response

#12956
20100021420
2010-01-28

COMBINATIONS OF PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDKS AND GSK'S

#12957
20100021416
2010-01-28

Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders

#12958
20100021402
2010-01-28

Compounds, formulations, and methods for ameliorating telangiectasis

#12959
20100016654
2010-01-21

Methods of Minimizing Immunological Rejection of A Nuclear Transfer Fetus

#12960
20100016587
2010-01-21

Protein kinase targeted therapeutics

#12961
20100016444
2010-01-21

Methods and compositions for treating mammalian nerve tissue injuries

#12962
20100016428
2010-01-21

Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events

#12963
20100016423
2010-01-21

USE OF DRONEDARONE FOR THE TREATMENT OF PATIENTS WITH ARRHYTHMIA AND HAVING AN INCREASE OF CREATININE LEVEL DUE TO DRONEDARONE ADMINISTRATION

#12964
20100016420
2010-01-21

Synergistic compositions consisting essentially of combinations of active agents selected from oridonin, wogonin, and isoliquiritigenin for the prevention of neoplasia

#12965
20100016418
2010-01-21

Cannabinoids for use in the treatment of neuropathic pain

#12966
20100016413
2010-01-21

Pathotropic targeted gene delivery system for cancer and other disorders

#12967
20100016407
2010-01-21

Combined telomerase inhibitor and gemcitabine for the treatment of cancer

#12968
20100016377
2010-01-21

Use of a p38 kinase inhibitor for treating psychiatric disorders

#12969
20100016363
2010-01-21

Fixed Combination Dosage Forms for the Treatment of Migraine

#12970
20100016355
2010-01-21

ALPHA-2B ADRENERGIC RECEPTOR AGONIST AND SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR COMPOSITIONS FOR TREATING CHRONIC PAIN

#12971
20100016344
2010-01-21

Amino heterocyclic linked pyrimidine derivatives

#12972
20100016338
2010-01-21

5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1-arylquinolin-2-ones, a Process for their Production and their Use as Anti-inflammatory Agents

#12973
20100016294
2010-01-21

METHODS FOR REDUCING THE RISK OF AN ADVERSE DRUG INTERACTION IN A PATIENT SUFFERING FROM INSOMNIA

#12974
20100016273
2010-01-21

Methods of treating cholesterol gallstone disease with ezetimibe

#12975
20100016262
2010-01-21

Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis

#12976
20100016256
2010-01-21

Taxane Compounds for Treating Eye Disease

#12977
20100016255
2010-01-21

Method of treating vitamin B12 deficiency

#12978
20100016249
2010-01-21

Cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof

#12979
20100016235
2010-01-21

Inhibitors of protein phosphatase 1, GADD34 and protein phosphatase 1/GADD34 complex, preparation and uses thereof

#12980
20100016214
2010-01-21

Carbohydrates mixture

#12981
20100016211
2010-01-21

Treatment of Melanoma With Alpha Thymosin Peptides

#12982
20100016210
2010-01-21

Sensotherapy

#12983
20100016208
2010-01-21

PHOTOACTIVATABLE ANTIMICROBIAL AGENTS

#12984
20100015261
2010-01-21

Herbal preparation for sleep apnea relief

#12985
20100015259
2010-01-21

Composition and method for improving human concentration, memory and other cognitive brain

#12986
20100015248
2010-01-21

Pharmaceutical composition

#12987
20100015247
2010-01-21

Carrageenan based antimicrobial compositions

#12988
20100015246
2010-01-21

COMBINATION OF A LANTHANUM COMPOUND AND BONE ENHANCING AGENT FOR THE TREATMENT OF BONE DISEASES

#12989
20100015242
2010-01-21

USE OF A COMPOSITION FOR SKIN TREATMENT UNDER X-IRRADIATION

#12990
20100015235
2010-01-21

COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS

#12991
20100015230
2010-01-21

Bone Morphogenetic Protein Compositions

#12992
20100015222
2010-01-21

Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

#12993
20100015220
2010-01-21

NIACIN AND NSAID COMBINATION THERAPY

#12994
20100015216
2010-01-21

METHODS AND MATERIALS FOR TREATING ACNE

#12995
20100015202
2010-01-21

Cancellous construct with support ring for repair of osteochondral defects

#12996
20100015174
2010-01-21

METHOD TO CONTROL DENGUE VIRUSES IN HUMANS BY PICOLINIC ACID AND DERIVATIVES THEREOF

#12997
20100015149
2010-01-21

Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases

#12998
20100015147
2010-01-21

Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside

#12999
20100015136
2010-01-21

Camptothecin-peptide conjugates and pharmaceutical compositions containing the same

#13000
20100015134
2010-01-21

Therapy with CD4 binding peptides and radiation

#13001
20100015119
2010-01-21

EPITHELIUM-IMPROVING AGENT

#13002
20100015118
2010-01-21

Supplement formula to prevent and deter muscle trauma and method of using same

#13003
20100015115
2010-01-21

Compound preparation for quickly reducing oxidative stress and preparation of the same

#13004
20100015111
2010-01-21

Methods And Kits For The Treatment Inhibition, And Maintenance Of Gastrointestinal Disorders

#13005
20100015109
2010-01-21

Composition for high-ORAC value dietary supplement

#13006
20100015099
2010-01-21

Nogo, Caspr, F3 NB-3 useful in the treatment of injury and disease to the central nervous system

#13007
20100015093
2010-01-21

Methods and compositions of treating a family viral infection

#13008
20100015092
2010-01-21

Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

#13009
20100015091
2010-01-21

MODIFIED STAT1 TRANSGENE THAT CONFERS INTERFERON HYPERRESPONSIVENESS, METHODS AND USES THEREFOR

#13010
20100015090
2010-01-21

Combinations for HCV Treatment

#13011
20100015088
2010-01-21

Compounds and compositions for delivering active agents

#13012
20100015086
2010-01-21

USE OF IL-22 FOR THE TREATMENT OF CONDITIONS OF METABOLIC DISORDERS

#13013
20100015049
2010-01-21

METHODS AND COMPOSITIONS FOR TREATING POSTOPERATIVE PAIN COMPRISING NONSTEROIDAL ANTI-INFLAMMATORY AGENTS

#13014
20100015042
2010-01-21

Combine radiation therapy and chemotherapy for treating cancer

#13015
20100010456
2010-01-14

System and Method for the Prevention of Bacterial and Fungal Infections Including Urinary Tract Infection (UTI) Using N-Halogenated Amino Acids

#13016
20100010417
2010-01-14

Radiation sensitizer or anti-cancer chemotherapy sensitizer

#13017
20100010097
2010-01-14

Methods for treating mild cognitive impairment and alzheimer's disease

#13018
20100010085
2010-01-14

Compositions and methods for treating jellyfish stings

#13019
20100010079
2010-01-14

Proanthocyanidins for the Treatment of Amyloid and Alpha-Synuclein Diseases

#13020
20100010064
2010-01-14

Cancer treatment by combined inhibition of proteasome and telomerase activities

#13021
20100010062
2010-01-14

METHOD OF TREATMENT USING EPROSARTAN

#13022
20100010046
2010-01-14

PHARMACEUTICAL FORMULATION FOR PARENTERAL ADMINISTRATION

#13023
20100010031
2010-01-14

TRANSORAL DOSAGE FORMS COMPRISING SUFENTANIL AND NALOXONE

#13024
20100010030
2010-01-14

Extended release hydrocodone acetaminophen and related methods and uses thereof

#13025
20100010029
2010-01-14

Acute Pain Medications Based on Fast Acting Diclofenac-Opioid Combinations

#13026
20100010026
2010-01-14

Statin and omega-3 fatty acids for reduction of Apo-B levels

#13027
20100010022
2010-01-14

CANCER TREATMENT METHOD

#13028
20100010005
2010-01-14

Improving renal function with quercetin-containing compositions

#13029
20100010002
2010-01-14

ANTICANCER USE OF CAFFEIC ACID AND ITS DERIVATIVES

#13030
20100009984
2010-01-14

AEROSOL FORMULATIONS FOR THE INHALATION OF BETA-AGONISTS

#13031
20100009970
2010-01-14

COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES

#13032
20100009967
2010-01-14

SOLID DOSAGE FORMULATIONS OF TELCAGEPANT POTASSIUM

#13033
20100009949
2010-01-14

NOVEL METHOD

#13034
20100009939
2010-01-14

CONCURRENT DRUGS

#13035
20100009930
2010-01-14

TREATMENT OF UTERINE CANCER AND OVARIAN CANCER WITH A PARP INHIBITOR ALONE OR IN CONBINATION WITH ANTI-TUMOR AGENTS

#13036
20100009924
2010-01-14

Compositions and methods for improving cardiovascular function

#13037
20100009906
2010-01-14

Anticancer Treatments

#13038
20100009447
2010-01-14

Vγ9Vδ2 T cell proliferation agent, method for producing activated Vγ9Vδ2 T cells, and uses thereof

#13039
20100009439
2010-01-14

Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs

#13040
20100009017
2010-01-14

Anticancer Methods Using Extracts of Anemarrhena asphodeloides Bunge

#13041
20100009014
2010-01-14

Use of composition for manufacture of medicant and method for inhibiting formation of body fat

#13042
20100009013
2010-01-14

METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN FOR NON-SMALL-CELL LUNG CANCER BASED ON BRCA1 EXPRESSION

#13043
20100009012
2010-01-14

CHEWABLE PHARYNGEAL INFLAMMATION SYMPTOM RELIEF COMPOSITION

#13044
20100009008
2010-01-14

BACTERIOSTATIC OR BACTERIOCIDAL COMPOSITIONS AND METHODS

#13045
20100009005
2010-01-14

Novel acetysalicylic acid formulations

#13046
20100008997
2010-01-14

COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND OTHER LUNG DISORDERS

#13047
20100008992
2010-01-14

Treatment of disc degenerative disease

#13048
20100008980
2010-01-14

Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined with Surgery, Chemotherapy or Radiotherapy for the Treatment of Cancer

#13049
20100008975
2010-01-14

Predicting response to a HER inhibitor

#13050
20100008936
2010-01-14

Methods of treatment using IL-16 antagonist peptides

#13051
20100008932
2010-01-14

USE OF SOLUBLE CD160 TO SUPPRESS IMMUNITY

#13052
20100008927
2010-01-14

Administration of (S)-roscovitine for protection against and/or treatment of neurological diseases

#13053
20100008923
2010-01-14

Organic Compounds

#13054
20100008917
2010-01-14

TREATMENT OF APLASTIC ANEMIA

#13055
20100008916
2010-01-14

Methods of inhibiting the lowering of antihuman TNF-α antibody

#13056
20100008913
2010-01-14

Methods and compositions for treating platelet-related disorders

#13057
20100008912
2010-01-14

COMBINATION DRUG

#13058
20100008900
2010-01-14

ANNEXIN II COMPOSITIONS FOR TREATING OR MONITORING INFLAMMATION OR IMMUNE-MEDIATED DISORDERS

#13059
20100008899
2010-01-14

METHODS OF DIAGNOSIS AND TREATMENT FOR METABOLIC DISORDERS

#13060
20100008896
2010-01-14

Use of fenretinide or bioactive derivatives thereof and pharmaceutical compositions comprising the same

#13061
20100008890
2010-01-14

MAPC therapeutics without adjunctive immunosuppressive treatment

#13062
20100008888
2010-01-14

Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas

#13063
20100008868
2010-01-14

SUSTAINED REMISSION OF ATOPIC DERMATITIS

#13064
20100008867
2010-01-14

METHOD OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS

#13065
20100008865
2010-01-14

Mixture of iron and copper salts masking metallic taste

#13066
20100004344
2010-01-07

ANTI-OXIDANT DIETARY COMPOSITION CONTAINING FRUITS AND VEGETABLES, METHOD FOR PREPARING THE SAME AND USE OF THE COMPOSITION

#13067
20100004330
2010-01-07

ANTI-OXIDATIVE CONTENT MATERIAL USED IN DRINK AND FOOD MANUFACTURING METHOD

#13068
20100004329
2010-01-07

ALCOHOL METABOLISM ENHANCER AND ALCOHOLIC BEVERAGE

#13069
20100004319
2010-01-07

Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease

#13070
20100004309
2010-01-07

Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging

#13071
20100004275
2010-01-07

AGENT FOR SUPPRESSING DEVELOPMENT OF TOLERANCE TO NARCOTIC ANALGESICS

#13072
20100004270
2010-01-07

Inhibitors of bruton's tyrosine kinase

#13073
20100004251
2010-01-07

Dopamine-agonist combination therapy for improving sleep quality

#13074
20100004247
2010-01-07

COMBINATION COMPRISING A MEK INHIBITOR AND AN AURORA KINASE INHIBITOR 188

#13075
20100004241
2010-01-07

NON-IMIDAZOLE ARYLOXYALKYLAMINES

#13076
20100004216
2010-01-07

Medicinal lipolysis of accumulation of fat

#13077
20100004215
2010-01-07

COMPOSITIONS OF PHOSPHODIESTERASE TYPE IV INHIBITORS

#13078
20100004214
2010-01-07

SEQUENTIAL SPRM/ PROGESTIN TREATMENT

#13079
20100004212
2010-01-07

DUAL PROTECTION OF MEDICINAL- PHARMACEUTICAL PRODUCTS AND NEW TECHNIQUES FOR THEIR APPLICATION

#13080
20100004205
2010-01-07

PHARMACEUTICAL COMPOSITIONS

#13081
20100004200
2010-01-07

Meloxicam and glucosamine formulation and uses thereof

#13082
20100004199
2010-01-07

GLYCINE BETAINE AND ITS USE

#13083
20100004196
2010-01-07

HEPARAN SULFATE PROTEOGLYCAN COMPOSITION AND USE THEREOF

#13084
20100004193
2010-01-07

COMBINATION THERAPY

#13085
20100004192
2010-01-07

4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication

#13086
20100004181
2010-01-07

COMBINATION COMPRISING N-(3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-(4-(1,3,4-OXADIAZOL-2-YL)PHENYL) PYRIDINE-3-SULPHONAMIDE AND AN LHRH ANALOGUE AND/OR A BISPHOSPHONATE

#13087
20100004156
2010-01-07

Small Compounds That Correct Protein Misfolding and Uses Thereof

#13088
20100003354
2010-01-07

Linseed Extract Medicament for Application to the Eye

#13089
20100003352
2010-01-07

Mucosal membrane healant and moisturizer

#13090
20100003351
2010-01-07

COMPOSITIONS COMPRISING RHODIOLA ROSEA AND METHODS OF USE THEREOF

#13091
20100003350
2010-01-07

COMPOSITION POSSESSING ANTIOXIDANT, IMMONOMODULATED, AND ANTITUMOROUS ACTION AND METHOD OF TREATING NEOPLASMS

#13092
20100003347
2010-01-07

Composition for preventing and treating fatty liver

#13093
20100003346
2010-01-07

COMBINATION METHODS OF TREATING CANCER

#13094
20100003334
2010-01-07

Combination of loteprednol etabonate and tobramycin for topical ophthalmic use

#13095
20100003333
2010-01-07

Compositions and methods for treating digestive disorders

#13096
20100003330
2010-01-07

Antimicrobial nanoemulsion compositions and methods

#13097
20100003321
2010-01-07

SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD OF MAKING THE SAME

#13098
20100003315
2010-01-07

Method and Composition for the Treatment of Skin Conditions

#13099
20100003314
2010-01-07

METHOD AND COMPOSITION FOR THE TREATMENT OF SKIN CONDITIONS

#13100
20100003311
2010-01-07

Antimicrobial Composition

#13101
20100003307
2010-01-07

COMPOSITION AND USE OF RAR ANTAGONISTS FOR PROMOTING CHONDROGENESIS

#13102
20100003302
2010-01-07

VASCULAR RESTENOSIS PREVENTING AGENT AND IMPLANTABLE INTRAVASCULAR DEVICE COATED THEREWITH

#13103
20100003289
2010-01-07

Controlled Release Complex Formulation For Oral Administration of Medicine For Diabetes and Method For The Preparation Thereof

#13104
20100003282
2010-01-07

Systems and methods for delivery of a therapeutic agent

#13105
20100003276
2010-01-07

Methods for treating anthrax and inhibiting lethal factor

#13106
20100003274
2010-01-07

FERMENTED COMPOSTIONS HAVING IMMUNODULATORY ACTIONS

#13107
20100003252
2010-01-07

BLOCKING IMMUNE RESPONSE TO A GRAFT

#13108
20100003238
2010-01-07

Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions

#13109
20100003224
2010-01-07

Combination Therapy

#13110
20100003222
2010-01-07

Methods for bone regeneration using endothelial progenitor cell preparations

#13111
20100003213
2010-01-07

4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication

#13112
20100003210
2010-01-07

External skin agent comprising modified clay for preventing inflammation

#13113
20100003198
2010-01-07

Antimicrobial Topical and Other Preparations Containing Fluorescent or Illumination Dye and Tracer Agents or Compounds

#13114
20100003192
2010-01-07

TREATMENT OF BREAST CANCER WITH A PARP INHIBITOR ALONE OR IN COMBINATION WITH ANTI-TUMOR AGENTS

#13115
20090326447
2009-12-31

Transdermal Delivery Apparatus and Method

#13116
20090326423
2009-12-31

Stimulation of cartilage formation using reduced pressure treatment

#13117
20090326202
2009-12-31

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)

#13118
20090326063
2009-12-31

Synthetic triterpenoids and methods of use in the treatment of disease

#13119
20090326056
2009-12-31

NOVEL ACTIVES AGAINST PROSTATE CARCINOMA

#13120
20090326037
2009-12-31

Medicinal Agent For Treating Viral Infections

#13121
20090326032
2009-12-31

PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS

#13122
20090326019
2009-12-31

3,4-BICYCLIC PYRROLIDINE ANTIVIRALS

#13123
20090326000
2009-12-31

RESVERATROL FORMULATIONS AND METHODS OF USE

#13124
20090325977
2009-12-31

CANCER COMBINATION THERAPY COMPRISING AZD2171 AND IMATINIB

#13125
20090325969
2009-12-31

Methotrexate adjuvants to reduce toxicity and methods for using the same

#13126
20090325943
2009-12-31

VETERINARY PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND INFLAMMATION

#13127
20090325938
2009-12-31

CONTROLLED-RELEASE CNS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#13128
20090325914
2009-12-31

Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy

#13129
20090325913
2009-12-31

Treatment of pain using satraplatin

#13130
20090325910
2009-12-31

Compositions and methods for tranquilizing heart muscle

#13131
20090325906
2009-12-31

Methods and compositions for therapeutic treatment

#13132
20090325898
2009-12-31

SKIN MATERIAL FOR EXTERNAL USE AND ANTIPRUTIRIC AGENT FOR EXTERNAL USE AND WRINKLE-INSTRUMENT USING THE SAME

#13133
20090325897
2009-12-31

Designer therapy of pancreatic tumors

#13134
20090325895
2009-12-31

Methods of treating an inflammatory-related disease

#13135
20090325893
2009-12-31

Doxorubicin adjuvants to reduce toxicity and methods for using the same

#13136
20090325891
2009-12-31

Cartilage regeneration-promoting agent

#13137
20090325888
2009-12-31

Peptides having a health benefit and compositions comprising them

#13138
20090325885
2009-12-31

Composition for acceleration of type I collagen production

#13139
20090325882
2009-12-31

Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion

#13140
20090325878
2009-12-31

ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY

#13141
20090325877
2009-12-31

Combination Product of Receptor Tyrosine Kinase Inhibitor and Fatty Acid Synthase Inhibitor for Treating Cancer

#13142
20090325868
2009-12-31

Materials and methods for FOXP3 tumor suppression

#13143
20090325856
2009-12-31

Composition Designed For The Treatment Of Multiple Sclerosis

#13144
20090324759
2009-12-31

IMMUNE ENHANCEMENT BY SEED OIL AND/OR SEED FLOUR

#13145
20090324758
2009-12-31

Plant extract mixtures and their uses

#13146
20090324755
2009-12-31

Method for the production of a plant-based medicament

#13147
20090324753
2009-12-31

Product and composition for alleviating post-menstrual symptoms

#13148
20090324751
2009-12-31

Chinese herb extract for treating dementia and preparation method thereof

#13149
20090324748
2009-12-31

TRAUMA THERAPY

#13150
20090324745
2009-12-31

COMPOSITIONS AND METHODS FOR NUTRITION SUPPLEMENTATION

#13151
20090324744
2009-12-31

Effective Antitumor Treatments

#13152
20090324740
2009-12-31

NOVEL NASAL SPRAY

#13153
20090324736
2009-12-31

METHODS OF TREATING BOWEL DISEASES BY ADMINISTERING A BOWEL CLEANSER AND AN ANTIBIOTIC

#13154
20090324734
2009-12-31

THROAT CARE COMPOSITION

#13155
20090324730
2009-12-31

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME

#13156
20090324729
2009-12-31

Use of solid carrier particles to improve the processability of a pharmaceutical agent

#13157
20090324715
2009-12-31

HIGH DOSE ORAL PHARMACEUTICAL COMPOSITIONS OF ARTEMETHER AND LUMEFANTRINE

#13158
20090324712
2009-12-31

METHODS AND COMPOSITIONS RELATED TO PRODUCTION OF COENZYME Q10

#13159
20090324705
2009-12-31

PHYTONUTRIENT COMPOSITIONS FOR TOPICAL USE

#13160
20090324701
2009-12-31

COMPOSITIONS CONTAINING (S)-BETHANECHOL AND THEIR USE IN THE TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES, GLUCOSE INTOLERANCE AND RELATED DISORDERS

#13161
20090324700
2009-12-31

METHODS AND COMPOSITIONS FOR THE INHIBITION OF CATHEPSINS

#13162
20090324697
2009-12-31

Transdermal hormone delivery system: compositions and methods

#13163
20090324678
2009-12-31

Methods and kits for treating joints and soft tissues

#13164
20090324669
2009-12-31

Osteogenic enhancer composition

#13165
20090324664
2009-12-31

SPRAY-ON, NON-WOVEN FABRIC SYSTEM AND MULTILAYER TOPICAL COVERING

#13166
20090324647
2009-12-31

Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use

#13167
20090324636
2009-12-31

FISH OIL IN STABILIZED FORM

#13168
20090324609
2009-12-31

METHOD OF TREATING AUTOIMMUNE DISEASE WITH MESENCHYMAL STEM CELLS

#13169
20090324607
2009-12-31

Therapeutic Transplantation Using Developing, Human or Porcine, Renal or Hepatic, Grafts

#13170
20090324587
2009-12-31

Cancer Therapies and Pharmaceutical Compositions Used Therein

#13171
20090324580
2009-12-31

Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases

#13172
20090324578
2009-12-31

Composition and method to treat wounds

#13173
20090324577
2009-12-31

6-11 Bicyclic Ketolide Derivatives

#13174
20090324572
2009-12-31

Methods and compositions for the treatment of symptoms of Williams Syndrome

#13175
20090324558
2009-12-31

Transdiscal administration of cycline compounds

#13176
20090324547
2009-12-31

Probiotic Oral Health Promoting Product

#13177
20090324544
2009-12-31

SUBSTITUTED CYCLIC PYRROLIDINE DERIVATIVES

#13178
20090324542
2009-12-31

SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS

#13179
20090324541
2009-12-31

Prophylactic or therapeutic agent for viral disease

#13180
20090324540
2009-12-31

Compounds and compositions for delivering active agents

#13181
20090324539
2009-12-31

Cancer treatment combining lymphodepleting agent with CTLs and cytokines

#13182
20090324518
2009-12-31

Novel Compositions Against Alkyl-Acyul-GPC The Derivatitves and Products Thereof

#13183
20090324510
2009-12-31

DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES

#13184
20090318711
2009-12-24

Non-Covalent Inhibitors of AmpC ß-Lactamase

#13185
20090318567
2009-12-24

LYCOPENE FOR THE TREATMENT OF METABOLIC DYSFUNCTION

#13186
20090318565
2009-12-24

Novel Compositions for the Enhancement of the Anti-oxidant Potential of Hydrogenated Curcuminoids or Combinations Thereof

#13187
20090318553
2009-12-24

Use of docosahexaenoic glycerides for the treatment of tumorous diseases

#13188
20090318534
2009-12-24

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND DISORDERS

#13189
20090318530
2009-12-24

PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS

#13190
20090318526
2009-12-24

Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia

#13191
20090318522
2009-12-24

Therapy for the treatment of disease

#13192
20090318520
2009-12-24

USE OF ISOINDOLES FOR THE TREATMENT OF NEUROBEHAVIORAL DISORDERS

#13193
20090318489
2009-12-24

Aporphine derivatives and pharmaceutical use thereof

#13194
20090318488
2009-12-24

Pharmaceutically acceptable salts of aporphine derivatives and carboxyl group-containing agents and methods for preparing the same

#13195
20090318480
2009-12-24

Method for treating cancer harboring EGFR mutations

#13196
20090318459
2009-12-24

Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor

#13197
20090318414
2009-12-24

Mono and Combination Therapy with M1/M4 Muscarinic Agonist (Sabcomeline) for Treatment of Prodromal Syndrome

#13198
20090318403
2009-12-24

ANTIBIOTIC COMPOSITION

#13199
20090318398
2009-12-24

ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION

#13200
20090318397
2009-12-24

Combination of azelastine and ciclesonide for nasal administration